Učitavanje...
BATCAVE: calling somatic mutations with a tumor- and site-specific prior
Detecting somatic mutations withins tumors is key to understanding treatment resistance, patient prognosis and tumor evolution. Mutations at low allelic frequency, those present in only a small portion of tumor cells, are particularly difficult to detect. Many algorithms have been developed to detec...
Spremljeno u:
| Izdano u: | NAR Genom Bioinform |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7003682/ https://ncbi.nlm.nih.gov/pubmed/32051931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nargab/lqaa004 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|